Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Optimizing MS Treatment Options
Establishing Partnerships to Optimize Patient Outcomes
Immunologic Effects on Metabolic Syndrome and MS
Highlights from the MAGNIMS Consensus Guidelines
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Current Landscape of MS Diagnosis/Prognosis
Determining an MS Patient's Long-Term Prognosis
Emerging MRI Techniques in MS Patients
The Value of Biomarkers in MS Patients
Current and Future MS Treatment Options
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying Global Neurology Academy…but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.
